Global Aortic Aneurysm Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023
Aortic aneurysm is a condition in which the aortic wall is enlarged at a certain point, which leads to rupturing of the artery resulting in internal bleeding. Abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) are the two types of aneurysms based on the location of the aneurysm. The first AAA surgical procedure was performed in 1991 and since then there has been an evolution in the treatment of stent grafts. Montenegro, Armenia, and New Zealand were the top three regions with highest mortality rate in 2013.
The increasing lifestyle diseases and smoking population are the factors that increase the chances for aortic aneurysm. Along with this, the growing aging population, favorable reimbursement, and technological advancements in products are driving the growth of the aortic aneurysm market. However, lack of awareness about the disease, stringent regulatory approval procedures, and risk associated with the procedure are hampering the growth of the market. The main unmet need in the market is endoleaking, which increases the mortality rate.
Currently, the market players are developing technologically advanced stent grafts for the treatment of complex aortic aneurysm repairs. The EVAR segment contributed more than 70% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the aortic aneurysm market in the future.
Market Analysis: The Global Aortic Aneurysm Market is estimated to witness a CAGR of 6.6% during the forecast period 2017-2023. The aortic aneurysm market is analyzed based on three segments - type, product types, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is set to be the leading region for the aortic aneurysm market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. Japan is the second standalone market after the US growing with a double digit CAGR.
Analysis by Types: The aortic aneurysm market is segmented into AAA and TAA. AAA occupies the major share in the market with EVAR being the most adopted AAA procedure. TAA is the fastest growing segment in the market. This is due to the technological advancements and the increasing awareness of the condition among the patients globally.
Analysis by Product Types: Based on products, the market is segmented as stent grafts, catheters, and other accessories. The stent grafts segment held the major share in 2016, and is expected to grow at a rate of 6.75% during the forecast period. Among the types of stent grafts, AAA stent grafts held a major share in 2016, and the rest of the market is held by TAA stent grafts.
Key Players: Cook Medical’s Medtronic PLC, W.L.Gore & Associates, MicroPort Scientific Corporation, Terumo Corporation, Endologix, Jotec GmbH, Boston Scientific Corporation, and other predominant and niche players.
Competitive Analysis: The market of aortic aneurysm is dominated by Cook Medical, Medtronic PLC, and W.L. Gore and Associates, who occupy around 85% of the market share. Other small players are adopting various strategies to increase their market share. Endologix acquired Trivascular to expand its product portfolio, thereby being able to address the current and future needs in the aortic aneurysm market.
In countries such as Australia, Germany, the US, and Switzerland, who have fee-for-service reimbursement system, the proportion undergoing AAA repair is higher compared with countries, such as Iceland, Sweden, Denmark, New Zealand, Hungary and Norway, who have a population-based reimbursement model.
Benefits: The report provides complete details about the usage and adoption rate of aortic aneurysm repair devices in various verticals and regions. These help the key stakeholders to know about the major trends, drivers, investments, and vertical player’s initiatives in the upcoming years. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
4 Market Outlook
4.1 Market Definition
4.2 Importance of Aortic Aneurysm Repair Devices
4.3 Complications of Aortic Aneurysm
4.4 Risk Factors for Aortic Aneurysm
4.5 Types of Aneurysm
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.2 Symptoms of Aortic Aneurysm
5.3 Market Dynamics
126.96.36.199 Rising geriatric population
188.8.131.52 High prevalence of tobacco smoking
184.108.40.206 Growing acceptance for minimally invasive endovascular surgeries
220.127.116.11 Favorable reimbursement conditions
18.104.22.168 Market expansion opportunities in emerging nations
22.214.171.124 Mergers & acquisitions
126.96.36.199 Increasing clinical trials
188.8.131.52 Stringent regulations for approval
184.108.40.206 Risk associated with the procedure
220.127.116.11 Lack of awareness
5.4 DRO - Impact Analysis
5.5 Key Stakeholders
6 Types: Market Size and Analysis
6.2 Abdominal Aortic Aneurysm
6.2.1 Procedure Type
18.104.22.168 Open surgery
22.214.171.124 Abdominal endovascular aneurysm repair
6.2.2 Location Types
6.3 Thoracic Aortic Aneurysm
6.3.1 Procedure Type
126.96.36.199 Open surgery
188.8.131.52 Thoracic endovascular aortic aneurysm
6.3.2 Location Types
7 Products: Market Size and Analysis
7.2 Stent Grafts
8 Regions: Market Size and Analysis
8.2 North America
8.4 Asia Pacific
8.4.4 New Zealand
8.5 Rest of the World
9 Competitive Landscape
10 Vendors Profile
10.1 MicroPort Scientific Corporation
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Medtronic Plc
10.2.2 Business Units
10.2.3 Geographic Presence
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Terumo Corp.
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Endologix Inc.
10.4.2 Geographic Presence
10.4.3 Business Focus
10.4.4 SWOT Analysis
10.4.5 Business Strategies
11 Companies to Watch For
11.1 Cook Medical Inc.
11.2 W.L. Gore & Associates
11.3 Maquet GmbH (Getinge Group)
11.4 Jotec GmbH
11.5 Boston Scientific Corp.
11.6 Lombard Medical Technologies PLC
- Boston Scientific Corp.
- Cook Medical Inc.
- Endologix Inc.
- Jotec GmbH
- Lombard Medical Technologies PLC
- Maquet GmbH (Getinge Group)
- Medtronic Plc
- MicroPort Scientific Corporation
- Terumo Corp.
- W.L. Gore & Associates